GABRIEL MARTIN: Open Payments
NPI 1376680462 · HARRISBURG, IL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$976 in 53 payments from 9 companies in 2025. Trend: 2023 $597 · 2024 $597 · 2025 $976
Food & beverage: $976
| Company | Payments | Amount |
|---|---|---|
| Alkermes, Inc. | 20 | $342 |
| ABBVIE INC. | 14 | $231 |
| E.R. Squibb & Sons, L.L.C. | 5 | $121 |
| Neurocrine BioSciences, Inc. | 6 | $116 |
| Otsuka America Pharmaceutical, Inc. | 4 | $83 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 1 | $25 |
| Braeburn Inc. | 1 | $22 |
| Lundbeck LLC | 1 | $20 |
| Janssen Pharmaceuticals, Inc | 1 | $17 |
Products named: ARISTADA, VRAYLAR, COBENFY, INGREZZA, REXULTI, CAPLYTA, BRIXADI, INVEGA SUSTENNA.
Industry payments across IL — which companies pay providers there.
